Primary Biliary Cholangitis Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1370421 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Primary Biliary Cholangitis Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Primary Biliary Cholangitis Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Primary Biliary Cholangitis Treatment Overall Market Size
    2.1 Global Primary Biliary Cholangitis Treatment Market Size: 2021 VS 2028
    2.2 Global Primary Biliary Cholangitis Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Primary Biliary Cholangitis Treatment Players in Global Market
    3.2 Top Global Primary Biliary Cholangitis Treatment Companies Ranked by Revenue
    3.3 Global Primary Biliary Cholangitis Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Primary Biliary Cholangitis Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Primary Biliary Cholangitis Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Primary Biliary Cholangitis Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Primary Biliary Cholangitis Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Primary Biliary Cholangitis Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Primary Biliary Cholangitis Treatment Market Size Markets, 2021 & 2028
        4.1.2 Ursodeoxycholic Acid (UDCA)
        4.1.3 Obeticholic Acid (Ocaliva)
    4.2 By Type - Global Primary Biliary Cholangitis Treatment Revenue & Forecasts
        4.2.1 By Type - Global Primary Biliary Cholangitis Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Primary Biliary Cholangitis Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Primary Biliary Cholangitis Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Primary Biliary Cholangitis Treatment Revenue & Forecasts
        5.2.1 By Application - Global Primary Biliary Cholangitis Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Primary Biliary Cholangitis Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Primary Biliary Cholangitis Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Primary Biliary Cholangitis Treatment Revenue & Forecasts
        6.2.1 By Region - Global Primary Biliary Cholangitis Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Primary Biliary Cholangitis Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Primary Biliary Cholangitis Treatment Revenue, 2017-2028
        6.3.2 US Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.3.3 Canada Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.3.4 Mexico Primary Biliary Cholangitis Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Primary Biliary Cholangitis Treatment Revenue, 2017-2028
        6.4.2 Germany Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.3 France Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.4 U.K. Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.5 Italy Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.6 Russia Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.4.8 Benelux Primary Biliary Cholangitis Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Primary Biliary Cholangitis Treatment Revenue, 2017-2028
        6.5.2 China Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.5.3 Japan Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.5.4 South Korea Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.5.6 India Primary Biliary Cholangitis Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Primary Biliary Cholangitis Treatment Revenue, 2017-2028
        6.6.2 Brazil Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.6.3 Argentina Primary Biliary Cholangitis Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Primary Biliary Cholangitis Treatment Revenue, 2017-2028
        6.7.2 Turkey Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.7.3 Israel Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Primary Biliary Cholangitis Treatment Market Size, 2017-2028
        6.7.5 UAE Primary Biliary Cholangitis Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Novartis
        7.1.1 Novartis Corporate Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Primary Biliary Cholangitis Treatment Major Product Offerings
        7.1.4 Novartis Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.1.5 Novartis Key News
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Corporate Summary
        7.2.2 Bristol-Myers Squibb Business Overview
        7.2.3 Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Major Product Offerings
        7.2.4 Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.2.5 Bristol-Myers Squibb Key News
    7.3 Pfizer
        7.3.1 Pfizer Corporate Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Primary Biliary Cholangitis Treatment Major Product Offerings
        7.3.4 Pfizer Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.3.5 Pfizer Key News
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Corporate Summary
        7.4.2 GlaxoSmithKline Business Overview
        7.4.3 GlaxoSmithKline Primary Biliary Cholangitis Treatment Major Product Offerings
        7.4.4 GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.4.5 GlaxoSmithKline Key News
    7.5 Teva Pharmaceutical
        7.5.1 Teva Pharmaceutical Corporate Summary
        7.5.2 Teva Pharmaceutical Business Overview
        7.5.3 Teva Pharmaceutical Primary Biliary Cholangitis Treatment Major Product Offerings
        7.5.4 Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.5.5 Teva Pharmaceutical Key News
    7.6 Retrophin
        7.6.1 Retrophin Corporate Summary
        7.6.2 Retrophin Business Overview
        7.6.3 Retrophin Primary Biliary Cholangitis Treatment Major Product Offerings
        7.6.4 Retrophin Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.6.5 Retrophin Key News
    7.7 Lumena Pharmaceuticals
        7.7.1 Lumena Pharmaceuticals Corporate Summary
        7.7.2 Lumena Pharmaceuticals Business Overview
        7.7.3 Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Major Product Offerings
        7.7.4 Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.7.5 Lumena Pharmaceuticals Key News
    7.8 Intercept Pharmaceuticals
        7.8.1 Intercept Pharmaceuticals Corporate Summary
        7.8.2 Intercept Pharmaceuticals Business Overview
        7.8.3 Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Major Product Offerings
        7.8.4 Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue in Global Market (2017-2022)
        7.8.5 Intercept Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Primary Biliary Cholangitis Treatment Market Opportunities & Trends in Global Market
    Table 2. Primary Biliary Cholangitis Treatment Market Drivers in Global Market
    Table 3. Primary Biliary Cholangitis Treatment Market Restraints in Global Market
    Table 4. Key Players of Primary Biliary Cholangitis Treatment in Global Market
    Table 5. Top Primary Biliary Cholangitis Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Primary Biliary Cholangitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Primary Biliary Cholangitis Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Primary Biliary Cholangitis Treatment Product Type
    Table 9. List of Global Tier 1 Primary Biliary Cholangitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Primary Biliary Cholangitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Primary Biliary Cholangitis Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Primary Biliary Cholangitis Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Primary Biliary Cholangitis Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Primary Biliary Cholangitis Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Primary Biliary Cholangitis Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Primary Biliary Cholangitis Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Novartis Corporate Summary
    Table 31. Novartis Primary Biliary Cholangitis Treatment Product Offerings
    Table 32. Novartis Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Bristol-Myers Squibb Corporate Summary
    Table 34. Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Product Offerings
    Table 35. Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Pfizer Corporate Summary
    Table 37. Pfizer Primary Biliary Cholangitis Treatment Product Offerings
    Table 38. Pfizer Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. GlaxoSmithKline Corporate Summary
    Table 40. GlaxoSmithKline Primary Biliary Cholangitis Treatment Product Offerings
    Table 41. GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Teva Pharmaceutical Corporate Summary
    Table 43. Teva Pharmaceutical Primary Biliary Cholangitis Treatment Product Offerings
    Table 44. Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Retrophin Corporate Summary
    Table 46. Retrophin Primary Biliary Cholangitis Treatment Product Offerings
    Table 47. Retrophin Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Lumena Pharmaceuticals Corporate Summary
    Table 49. Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Product Offerings
    Table 50. Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Intercept Pharmaceuticals Corporate Summary
    Table 52. Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Product Offerings
    Table 53. Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Primary Biliary Cholangitis Treatment Segment by Type in 2021
    Figure 2. Primary Biliary Cholangitis Treatment Segment by Application in 2021
    Figure 3. Global Primary Biliary Cholangitis Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Primary Biliary Cholangitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Primary Biliary Cholangitis Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Primary Biliary Cholangitis Treatment Revenue in 2021
    Figure 8. By Type - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 12. US Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 24. China Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Primary Biliary Cholangitis Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Primary Biliary Cholangitis Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Novartis Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pfizer Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. GlaxoSmithKline Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Teva Pharmaceutical Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Retrophin Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Primary Biliary Cholangitis Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Primary Biliary Cholangitis Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Primary Biliary Cholangitis Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Paper Straws Market

A Paper Straw is a small pipe made of paper material that allows its user to more conveniently co ... Read More